explore -WSS

explore

author：Wikipedia 2025-10-02 06:32:47 - browse：981

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Study links childhood stress with decline in older age

hotspot

WSS

'Revelatory' study finds a smoking impact that remains after quitting

Why did Pfizer dish out millions for a Super Bowl ad?

Robert F. Kennedy is pitching centrism on health, even on abortion

A disappointing year of Humira biosimilars

The Readout: Gilead, Bernie Sanders, and other pharma news

Florida officials tell state schools to teach AP Psychology 'in its entirety'

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

How digital tools helped lower hypertension in marginalized patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study links childhood stress with decline in older age

Anesthesiologist group: stop taking Ozempic before surgery

Private equity deals in Medicare Advantage declines

Guidelines to prevent youth baseball injuries need more muscle

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Affirmative action in medical school literally saved lives

Alnylam reports growth in sales of rare disease treatments

entertainment

Alnylam reports growth in sales of rare disease treatments

PhRMA lawsuit over Medicare drug price negotiation tossed

Senators start work on Medicare physician payment reform

Doctors' information doesn't help them choose wisely when sick

How digital tools helped lower hypertension in marginalized patients

How I helped Pfizer think through the ethics of Viagra

hotspot

focus

explore

hotspot